June 2026 Ingredion announced the acquisition of Tate & Lyle in a transaction valued at approximately USD 5.0 billion, creating a larger global specialty ingredients company with expanded capabilities in sugar reduction, sweetening solutions, and polyol-based ingredient applications, including xylitol.
May 2026 Ingredion entered a strategic joint venture with Sanstar Limited and acquired an equity stake in the company to expand specialty ingredient manufacturing and formulation capabilities in India, strengthening its presence in food, pharmaceutical, and sweetener ingredient markets.
June 2025 Haleon announced a GBP 175 million investment to establish a new oral health manufacturing facility in India, expanding production capacity for oral care products that utilize sugar alcohol ingredients such as xylitol in toothpaste and chewing gum formulations.
May 2025 Roquette completed the acquisition of IFF Pharma Solutions, expanding its pharmaceutical excipient portfolio and strengthening formulation capabilities for sugar alcohol-based ingredients, including xylitol applications in oral care and drug delivery.